Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Outstanding
Ratios

Alaunos Therapeutics (TCRT) Shares Repurchased (2016 - 2018)

Historic Shares Repurchased for Alaunos Therapeutics (TCRT) over the last 8 years, with Q4 2018 value amounting to $347000.0.

  • Alaunos Therapeutics' Shares Repurchased rose 13330.13% to $347000.0 in Q4 2018 from the same period last year, while for Dec 2022 it was $347000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $45000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Alaunos Therapeutics reported Shares Repurchased of $347000.0 as of Q4 2018, which was up 13330.13% from $544000.0 recorded in Q2 2018.
  • In the past 5 years, Alaunos Therapeutics' Shares Repurchased registered a high of $851000.0 during Q2 2016, and its lowest value of -$1.0 million during Q4 2017.
  • For the 5-year period, Alaunos Therapeutics' Shares Repurchased averaged around $68000.0, with its median value being $133000.0 (2015).
  • In the last 5 years, Alaunos Therapeutics' Shares Repurchased crashed by 14666.67% in 2016 and then soared by 13330.13% in 2018.
  • Quarter analysis of 5 years shows Alaunos Therapeutics' Shares Repurchased stood at $132000.0 in 2014, then tumbled by 361.36% to -$345000.0 in 2015, then tumbled by 146.67% to -$851000.0 in 2016, then fell by 22.44% to -$1.0 million in 2017, then surged by 133.3% to $347000.0 in 2018.
  • Its Shares Repurchased was $347000.0 in Q4 2018, compared to $544000.0 in Q2 2018 and $731000.0 in Q1 2018.